Have a personal or library account? Click to login
The Potential of Fractional Exhaled Nitric Oxide as a Biomarker in Predicting and Optimizing Use of Treatment in Asthma Cover

The Potential of Fractional Exhaled Nitric Oxide as a Biomarker in Predicting and Optimizing Use of Treatment in Asthma

South East European Journal of Immunology
Volume 6 (2023): Issue 1 (December 2023)
By: Hirowati Ali,  Salsabila Faiha Wiendra Rasya and  Muhammad Abi Ghoffari Siregar  
Open Access
|Jan 2024

Authors

Hirowati Ali

hirowatiali@med.unand.ac.id

Department of Biochemistry, Faculty of Medicine, Andalas University, Indonesia
Graduate School of Biomedical Sciences, Faculty of Medicine, Andalas University, Indonesia
Biomedical Laboratory, Faculty of Medicine, Andalas University, Indonesia

Salsabila Faiha Wiendra Rasya

Department of Biochemistry, Faculty of Medicine, Andalas University, Indonesia

Muhammad Abi Ghoffari Siregar

Department of Biochemistry, Faculty of Medicine, Andalas University, Indonesia
DOI: https://doi.org/10.3889/seejim.2022.6033 | Journal eISSN: 1857-9388
Journal RSS Feed
Language: English
Page range: 18 - 23
Submitted on: Mar 15, 2023
Accepted on: May 19, 2023
Published on: Jan 3, 2024
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Asthma,
Biomarkers,
Fractional Exhaled Nitric Oxide
Related subjects:
Medicine,
Basic medical science,
Immunology,
Clinical medicine,
Laboratory medicine

© 2024 Hirowati Ali, Salsabila Faiha Wiendra Rasya, Muhammad Abi Ghoffari Siregar, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 6 (2023): Issue 1 (December 2023)Next article